Open Access
Volume 18, Number 2, Mars-Avril 2011
Dossier : Vitamines liposolubles
Page(s) 47 - 52
Section Nutrition – Santé
Published online 15 March 2011
  • Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007 ; 28 : 176–183. [CrossRef] [PubMed] [Google Scholar]
  • Aveldaño MI, Sprecher H. Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. J Biol Chem 1983 ; 258 : 9339–9343. [PubMed] [Google Scholar]
  • Authi KS, Lagarde M, Crawford N. Diacylglycerol lipase activity in human platelet intracellular and surface membranes. Some kinetic properties and fatty acid specificity. FEBS Lett 1985 ; 180 : 95–101. [CrossRef] [PubMed] [Google Scholar]
  • Balsinde J, Balboa MA, Dennis EA. Group IV cytosolic phospholipase A2 activation by diacylglycerol pyrophosphate in murine P388D1 macrophages. Ann N Y Acad Sci 2000 ; 905 : 11–15. [Google Scholar]
  • Blée E. Impact of phyto-oxylipins in plant defense. Trends Plant Sci 2002 ; 7 : 315–322. [CrossRef] [PubMed] [Google Scholar]
  • Bordet JC, Guichardant M, Lagarde M. Arachidonic acid strongly stimulates prostaglandin I3 (PGI3) production from eicosapentaenoic acid in human endothelial cells. Biochem Biophys Res Commun 1986 ; 135 : 403–410. [CrossRef] [PubMed] [Google Scholar]
  • Bordet JC, Guichardant M, Lagarde M. Hydroperoxides produced by n-6 lipoxygenation of arachidonic and linoleic acids potentiate synthesis of prostacyclin related compounds. Biochim Biophys Acta 1988 ; 958 : 460–468. [CrossRef] [PubMed] [Google Scholar]
  • Borgeat P. Biochemistry of the lipoxygenase pathways in neutrophils. Can J Physiol Pharmacol 1989 ; 67 : 936–942. [Google Scholar]
  • Boukhchache D, Lagarde M. Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta 1982 ; 713 : 386–392. [CrossRef] [PubMed] [Google Scholar]
  • Bryant RW, Bailey JM. Role of selenium-dependent glutathione peroxidase in platelet lipoxygenase metabolism. Prog Lipid Res 1981 ; 20 : 189–194. [CrossRef] [PubMed] [Google Scholar]
  • Buchanan MR, Haas TA, Lagarde M, Guichardant M. 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor LOX. J Biol Chem 1985 ; 260 : 16056–16059. [PubMed] [Google Scholar]
  • Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000 ; 41 : 163–181. [PubMed] [Google Scholar]
  • Capdevila JH, Falck JR, Imig JD. Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. Kidney Int 2007 ; 72 : 683–689. [CrossRef] [PubMed] [Google Scholar]
  • Chen P, Véricel E, Lagarde M, Guichardant M. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 2011 ; 25 : 382–388. [CrossRef] [PubMed] [Google Scholar]
  • Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 1983 ; 80 : 3581–3584. [CrossRef] [PubMed] [Google Scholar]
  • Croset M, Lagarde M. Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid. Lipids 1985 ; 20 : 743–750. [CrossRef] [PubMed] [Google Scholar]
  • Colas R, Pruneta-Deloche V, Guichardant M, et al. Increased lipid peroxidation in LDL from type-2 diabetic patients. Lipids 2010 ; 45 : 723–731. [CrossRef] [PubMed] [Google Scholar]
  • Croset M, Sala A, Folco G, Lagarde M. Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle 14-Hydroxy from 22:6n–3 is more potent than 12-HETE. Biochem Pharmacol 1988 ; 37 : 1275–1280. [CrossRef] [PubMed] [Google Scholar]
  • Dangi B, Obeng M, Nauroth JM, et al. Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). J Biol Chem 2009 ; 284 : 14744–14759. [CrossRef] [PubMed] [Google Scholar]
  • Hamberg M. Steric analysis of hydroperoxides formed by lipoxygenase oxygenation of linoleic acid. Anal Biochem 1971 ; 43 : 515–526. [CrossRef] [PubMed] [Google Scholar]
  • Hamberg M, Samuelsson B. Prostaglandin endoperoxides Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A 1974 ; 71 : 3400–3404. [CrossRef] [PubMed] [Google Scholar]
  • Hecker M, Ullrich V. On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 1989 ; 264 : 141–150. [PubMed] [Google Scholar]
  • Jakschik BA, Morrison AR, Sprecher H. Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway. J Biol Chem 1983 ; 258 : 12797–12800. [PubMed] [Google Scholar]
  • Kaduce TL, Figard PH, Leifur R, Spector AA. Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J Biol Chem 1989 ; 264 : 6823–6830. [PubMed] [Google Scholar]
  • Kuo CG, Lewis MT, Jakschik BA. Leukotriene D4 and E4 formation by plasma membrane bound enzymes. Prostaglandins 1984 ; 28 : 929–938. [CrossRef] [PubMed] [Google Scholar]
  • Lagarde M. Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. Prog Lipid Res 1988 ; 27 : 135–152. [CrossRef] [PubMed] [Google Scholar]
  • Lagarde M, Burtin M, Rigaud M, Sprecher H, Dechavanne M, Renaud S. Prostaglandin E2-like activity of 20:3n–9 platelet lipoxygenase end-product. FEBS Lett 1985 ; 181 : 53–56. [CrossRef] [PubMed] [Google Scholar]
  • Lagarde M, Burtin M, Sprecher H, Dechavanne M, Renaud S. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. Lipids 1983 ; 18 : 291–294. [CrossRef] [PubMed] [Google Scholar]
  • Laneuville O, Breuer DK, Xu N, et al. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2 Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem 1995 ; 270 : 19330–19336. [CrossRef] [PubMed] [Google Scholar]
  • Leaf A. Health claims: omega-3 fatty acids and cardiovascular disease. Nutr Rev 1992 ; 50 : 150–154. [Google Scholar]
  • Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 1984 ; 74 : 1922–1933. [CrossRef] [PubMed] [Google Scholar]
  • Lukiw WJ, Bazan NG. Inflammatory, apoptotic, and survival gene signaling in Alzheimer’s disease A review on the bioactivity of neuroprotectin D1 and apoptosis. Mol Neurobiol 2010 ; 42 : 10–16. [CrossRef] [PubMed] [Google Scholar]
  • Makita K, Falck JR, Capdevila JH. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J. 1996 ; 10 : 1456–1463. [PubMed] [Google Scholar]
  • Milks MM, Sprecher H. Metabolism of 4,7,10,13,16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase. Biochim Biophys Acta 1985 ; 835 : 29–35. [CrossRef] [PubMed] [Google Scholar]
  • Morita I, Takahashi R, Saito Y, Murota S. Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J Biol Chem 1983 ; 258 : 10197–10199. [PubMed] [Google Scholar]
  • Oliw EH. Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog Lipid Res 1994 ; 33 : 329–354. [CrossRef] [PubMed] [Google Scholar]
  • Patrono C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back.n. Trends Pharmacol Sci 1989 ; 10 : 453–8. [CrossRef] [PubMed] [Google Scholar]
  • Renaud S. Dietary fats and atherosclerosis in rat and rabbit. Adv Cardiol 1974 ; 13 : 169–182. [PubMed] [Google Scholar]
  • Salem Jr N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001 ; 36 : 945–959. [CrossRef] [PubMed] [Google Scholar]
  • Serhan CN, Yang R, Martinod K, et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 2009 ; 206 : 15–23. [CrossRef] [PubMed] [Google Scholar]
  • Smith WL. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol 1986 ; 48 : 251–262. [CrossRef] [PubMed] [Google Scholar]
  • Smith WL. Nutritionally essential fatty acids and biologically indispensable cyclooxygenases. Trends Biochem Sci 2008 ; 33 : 27–37. [CrossRef] [PubMed] [Google Scholar]
  • Vanderhoek JY. Role of the 15-lipoxygenase in the immune system. Ann N Y Acad Sci. 1988 ; 524 : 240–251. [CrossRef] [PubMed] [Google Scholar]
  • VanRollins M, Horrocks L, Sprecher H. Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets. Biochim Biophys Acta 1985 ; 833 : 272–280. [CrossRef] [PubMed] [Google Scholar]
  • Werz O, Bürkert E, Samuelsson B, Rådmark O, Steinhilber D. Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. Blood 2002 ; 99 : 1044–1052. [Google Scholar]
  • Wu KK, Papp AC, Manner CE, Hall ER. Interaction between lymphocytes and platelets in the synthesis of prostacyclin. J Clin Invest 1987 ; 79 : 1601–1606. [CrossRef] [PubMed] [Google Scholar]
  • Yamamoto K, Ninomiya Y, Iseki M, et al. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis. Biochem Biophys Res Commun 2008 ; 367 : 566–572. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.